Leading Healthcare Investors, including Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital ...
Inconsistent reporting at a Pennsylvania site affected microbiological analyses of components and drug products that ...
AstraZeneca will tap AI-focused insitro to find new targets for metabolic dysfunction-associated steatohepatitis and ...
Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced its ...
Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the ...
GE HealthCare (Nasdaq: GEHC) today announced the publication of research conducted at the University of Michigan iv ...
Arrowhead Pharmaceuticals’ siRNA candidate achieved “compelling” tau reductions in an early study of healthy volunteers, with ...
Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel ...
The sixth cycle of OrbiMed’s Asia Partners fund included one with more than $1 billion earmarked for life science companies ...
After years of quiet maturation, new approach methodologies and emerging clinical success for cell therapies are fueling ...
New mechanistic research and clinician-reported real-world experience adds to the evolving evidence base for birch ...
Following several recent initiatives, the FDA's newest rare disease framework sets out to standardize the agency's approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results